Absci (ABSI) Total Non-Current Liabilities (2020 - 2026)

Absci's (ABSI) quarterly Total Non-Current Liabilities came in at $22.8 million in Q1 2026, down 28.62% year-on-year from $32.0 million in Q1 2025, and down 11.65% quarter-over-quarter from $25.8 million in Q4 2025.

Absci (ABSI) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

Absci has disclosed Total Non-Current Liabilities across 7 years of filings, most recently posting $22.8 million for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $22.8 million, down 28.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $22.8 million (down 28.62% YoY), and the FY2025 annual result was $25.8 million, down 24.8% from the prior year.
  • Total Non-Current Liabilities came in at $22.8 million for Q1 2026 at Absci, down from $25.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $54.7 million in Q1 2022 to a low of $22.8 million in Q1 2026.
  • The 5-year median for Total Non-Current Liabilities is $35.0 million (2025), against an average of $37.9 million.
  • Across the five-year window, Total Non-Current Liabilities sank 75.66% in 2022 and climbed 2.97% in 2025, its largest moves.
  • Absci's Total Non-Current Liabilities stood at $46.6 million in 2022, then decreased by 12.31% to $40.8 million in 2023, then dropped by 15.88% to $34.3 million in 2024, then fell by 24.8% to $25.8 million in 2025, then fell by 11.65% to $22.8 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $22.8 million (Q1 2026), $25.8 million (Q4 2025), and $32.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Absci 1.13 Bn 1.01 Bn - 22.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 22.82 Mn
Dec 31, 2025 25.83 Mn
Sep 30, 2025 32.87 Mn
Jun 30, 2025 35.04 Mn
Mar 31, 2025 31.97 Mn
Dec 31, 2024 34.34 Mn
Sep 30, 2024 33.87 Mn
Jun 30, 2024 34.03 Mn
Mar 31, 2024 34.71 Mn
Dec 31, 2023 40.83 Mn
Sep 30, 2023 39.93 Mn
Jun 30, 2023 38.75 Mn
Mar 31, 2023 41.84 Mn
Dec 31, 2022 46.56 Mn
Sep 30, 2022 46.41 Mn
Jun 30, 2022 49.90 Mn
Mar 31, 2022 54.74 Mn
Dec 31, 2021 47.93 Mn
Sep 30, 2021 48.98 Mn
Jun 30, 2021 204.96 Mn